Cholangiocarcinoma—evolving concepts and therapeutic strategies
SI Ilyas, SA Khan, CL Hallemeier, RK Kelley… - Nature reviews Clinical …, 2018 - nature.com
Cholangiocarcinoma is a disease entity comprising diverse epithelial tumours with features
of cholangiocyte differentiation: cholangiocarcinomas are categorized according to …
of cholangiocyte differentiation: cholangiocarcinomas are categorized according to …
Comparative effectiveness of biliary brush cytology and intraductal biopsy for detection of malignant biliary strictures: a systematic review and meta-analysis
U Navaneethan, B Njei, V Lourdusamy… - Gastrointestinal …, 2015 - Elsevier
Background Evaluation of indeterminate biliary strictures typically involves collection and
analysis of tissue or cells. Brush cytology and intraductal biopsies that are routinely …
analysis of tissue or cells. Brush cytology and intraductal biopsies that are routinely …
Epidemiology of cholangiocarcinoma
A Bergquist, E von Seth - Best practice & research Clinical …, 2015 - Elsevier
Cholangiocarcinoma (CCA) is a cancer arising from the intra-or extrahepatic bile ducts and
mainly characterized by its late diagnosis and fatal outcome. CCA is the second most …
mainly characterized by its late diagnosis and fatal outcome. CCA is the second most …
Primary sclerosing cholangitis
GM Hirschfield, TH Karlsen, KD Lindor, DH Adams - The Lancet, 2013 - thelancet.com
Primary sclerosing cholangitis is the classic hepatobiliary manifestation of inflammatory
bowel disease and is generally chronic and progressive. Patients frequently present with …
bowel disease and is generally chronic and progressive. Patients frequently present with …
[PDF][PDF] Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma
A Arbelaiz, M Azkargorta, M Krawczyk… - …, 2017 - Wiley Online Library
Cholangiocarcinoma (CCA) includes a heterogeneous group of biliary cancers with poor
prognosis. Several conditions, such as primary sclerosing cholangitis (PSC), are risk factors …
prognosis. Several conditions, such as primary sclerosing cholangitis (PSC), are risk factors …
Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management
Primary sclerosing cholangitis (PSC), first described in the mid-1850s, is a complex liver
disease that is heterogeneous in its presentation. PSC is characterized by chronic …
disease that is heterogeneous in its presentation. PSC is characterized by chronic …
Single-operator cholangioscopy and targeted biopsies in the diagnosis of indeterminate biliary strictures: a systematic review
U Navaneethan, MK Hasan, V Lourdusamy… - Gastrointestinal …, 2015 - Elsevier
Background and Aims Evaluation of indeterminate biliary strictures by brush cytology and
intraductal biopsies is limited by low sensitivity. The utility of SpyGlass peroral …
intraductal biopsies is limited by low sensitivity. The utility of SpyGlass peroral …
Label-free quantification in clinical proteomics
DA Megger, T Bracht, HE Meyer, B Sitek - Biochimica et Biophysica Acta …, 2013 - Elsevier
Nowadays, proteomic studies no longer focus only on identifying as many proteins as
possible in a given sample, but aiming for an accurate quantification of them. Especially in …
possible in a given sample, but aiming for an accurate quantification of them. Especially in …
Biliary strictures: diagnostic considerations and approach
A Singh, A Gelrud, B Agarwal - Gastroenterology report, 2015 - academic.oup.com
Biliary strictures present a diagnostic challenge, especially when no etiology can be
ascertained after laboratory evaluation, abdominal imaging and endoscopic retrograde …
ascertained after laboratory evaluation, abdominal imaging and endoscopic retrograde …
Peptidomics and proteomics based on CE‐MS as a robust tool in clinical application: The past, the present, and the future
Capillary electrophoresis combined with mass spectrometry (CE‐MS) has been used for
several years for the investigation of proteins and peptides as biomarkers for diagnosis and …
several years for the investigation of proteins and peptides as biomarkers for diagnosis and …